Search across episodes, people, companies, and topics — or ask the AI agent for deeper research and structured analysis.

Browse all available podcasts, episodes, and categories. Explore Technology shows and discover new content to follow.

Manage your subscribed podcasts. New episodes are automatically analyzed with AI when published, so you never miss important discussions.

Your AI analysis feed. Every episode you analyze appears here with key insights, summaries, and extracted intelligence.

Browse individuals mentioned across analyzed episodes. See who's being discussed, in what context, and how often.

Track companies and organizations referenced in podcast discussions. Monitor brand mentions and competitive intelligence.

Explore recurring topics and themes extracted from analyzed episodes. Discover what subjects are driving podcast conversations.

Spot emerging trends identified by AI across analyzed episodes. See what's gaining momentum in podcast discussions.

Browse brands and advertisers identified across analyzed episodes. See which companies sponsor which shows and how often.

Rich Miller

Mentioned in 2 analyzed podcast episodes across 1 show

Appears On

The Peter Attia Drive

Episode Appearances

The Peter Attia Drive

The Peter Attia Drive · Apr 6, 2026

#386 - Aging clocks—what they measure, how they work, and their clinical and real-world relevance

“Oversees ITP drug testing program; previous podcast guest discussing proteome-based aging rate calculators”

Epigenetic clocks and DNA methylation as aging biomarkersBiological age vs. chronological age vs. pace of agingClinical trial design for longevity interventions

The Peter Attia Drive

The Peter Attia Drive · Aug 4, 2025

#359 ‒ How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more | Eric Verdin, M.D.

“Director of Intervention Testing Program (ITP) studying drugs that extend lifespan in mice”

NAD metabolism and CD38 inhibitionEpigenetic aging clocks and their limitationsThymic involution and immune aging